These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 28392639)
21. Which factors influence Demodex proliferation? A retrospective pilot study highlighting a possible role of subtle immune variations and sebaceous gland status. Forton FMN; De Maertelaer V J Dermatol; 2021 Aug; 48(8):1210-1220. PubMed ID: 33969532 [TBL] [Abstract][Full Text] [Related]
22. Biologic therapy increases Demodex density in psoriasis patients. Aksoy H; Altıntaş Kakşi S; Gönüllü Ö; Aslan Kayıran M; Erdemir VA Int J Dermatol; 2024 Sep; 63(9):1193-1199. PubMed ID: 38650106 [TBL] [Abstract][Full Text] [Related]
23. Demodex folliculorum and Demodex brevis as a cause of chronic marginal blepharitis. Czepita D; Kuźna-Grygiel W; Czepita M; Grobelny A Ann Acad Med Stetin; 2007; 53(1):63-7; discussion 67. PubMed ID: 18561612 [TBL] [Abstract][Full Text] [Related]
24. Density of Demodex folliculorum in rosacea: a case-control study using standardized skin-surface biopsy. Forton F; Seys B Br J Dermatol; 1993 Jun; 128(6):650-9. PubMed ID: 8338749 [TBL] [Abstract][Full Text] [Related]
25. Role of Adenosine Deaminase in Patients with Erythematotelangiectatic Rosacea and Sener S; Karaman U; Kiran TR; Colak C; Aslan A; Direkel S Iran J Parasitol; 2020; 15(4):596-601. PubMed ID: 33884017 [TBL] [Abstract][Full Text] [Related]
26. Efficacy and safety of permethrin 5% topical gel vs. placebo for rosacea: a double-blind randomized controlled clinical trial. Raoufinejad K; Mansouri P; Rajabi M; Naraghi Z; Jebraeili R J Eur Acad Dermatol Venereol; 2016 Dec; 30(12):2105-2117. PubMed ID: 27600257 [TBL] [Abstract][Full Text] [Related]
27. Treatment of rosacea and demodicosis with benzyl benzoate: effects of different doses on Demodex density and clinical symptoms. Forton FMN; De Maertelaer V J Eur Acad Dermatol Venereol; 2020 Feb; 34(2):365-369. PubMed ID: 31494991 [TBL] [Abstract][Full Text] [Related]
28. Prevalence of ocular demodicosis among patients at Tertiary Care Center, Bangkok, Thailand. Kasetsuwan N; Kositphipat K; Busayarat M; Threekhan P; Preativatanyou K; Phumee A; Siriyasatien P Int J Ophthalmol; 2017; 10(1):122-127. PubMed ID: 28149788 [TBL] [Abstract][Full Text] [Related]
34. The effect of phototherapy on Demodex density: a case-control study. Aksoy H; Aslan Kayıran M; Dede Y; Altıntaş Kakşi S; Erdemir VA Int J Dermatol; 2024 Feb; 63(2):201-206. PubMed ID: 38234255 [TBL] [Abstract][Full Text] [Related]
35. Human demodicosis: revisit and a proposed classification. Chen W; Plewig G Br J Dermatol; 2014 Jun; 170(6):1219-25. PubMed ID: 24471456 [TBL] [Abstract][Full Text] [Related]
36. [Frequency of the appearance of Demodex sp. in various patient and age groups]. Aycan OM; Otlu GH; Karaman U; Daldal N; Atambay M Turkiye Parazitol Derg; 2007; 31(2):115-8. PubMed ID: 17594651 [TBL] [Abstract][Full Text] [Related]
37. Dermoscopy as a clinical tool for the diagnosis of demodicosis: a retrospective intrapatient case-control study. Parra-Cares J; Meza-Romero R; Ibáñez S; Canales M; Concha M; Navarrete-Dechent C; Abarzúa-Araya Á Arch Dermatol Res; 2024 Aug; 316(8):509. PubMed ID: 39126525 [TBL] [Abstract][Full Text] [Related]
38. [Human Demodicosis: Emerging Dermatosis Caused by Demodex]. Zhao YE Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2016 Oct; 34(5):456-62. PubMed ID: 30130041 [TBL] [Abstract][Full Text] [Related]
39. Effectiveness of benzyl benzoate treatment on clinical symptoms and Demodex density over time in patients with rosacea and demodicosis: a real life retrospective follow-up study comparing low- and high-dose regimens. Forton FMN; De Maertelaer V J Dermatolog Treat; 2022 Feb; 33(1):456-465. PubMed ID: 32427504 [TBL] [Abstract][Full Text] [Related]